Brazil's GMP Guideline Available in English
Recommendation
26/27 June 2025
Barcelona, Spain
Supervision of the Pharmaceutical Supply Chain: Challenges and Opportunities
Register now for ECA's GMP Newsletter
In a globalised world, it is interesting to consider pharmaceutical markets outside the classical regions Europe, USA and Japan like, for example, South America. Conversely, this means that the monitoring authority in the country which imports medicinal products is able to perform a GMP inspection of the exporter.
The Brazilian monitoring authority ANVISA is definitely known in Europe. Of course, these authorities have their own GMP inspection requirements. In this respect, having the inspection documents in English is useful. The ANVISA also provides its GMP requirements in English which you can find here.
Related GMP News
28.05.2025A View on the EU Critical Medicines Act to secure Pharma Supply Chains
20.05.2025Summary Data on Registration and Listing of Cosmetic Facilities and Products
07.05.2025FDA is extending its Quality Management Maturity Programme
30.04.2025FDA Warning Letter on missing Audit Trails and Raw Data Review
23.04.2025New WHO Guideline Package: TRS 1060 published
16.04.2025EMA: QPs must provide a written final Assessment and Approval of Third-Party Audit Reports